Prodia Widyahusada Tbk. vs Trimegah Karya Pratama Tbk. — how do they compare? Prodia Widyahusada Tbk. trades at Rp2,390 (market cap 2.24T, 260.1K 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp150 (market cap 312.02B, 65.66M 24h volume). The key difference: Prodia Widyahusada Tbk. is far larger — about 7.2× Trimegah Karya Pratama Tbk.'s market cap, and Trimegah Karya Pratama Tbk. is more actively traded (65.66M versus 260.1K). Which is the better fit depends on your goals.
| PRDA | UVCR | |
|---|---|---|
Market Cap | 2.24T | 312.02B |
Volume | 260.1K | 65.66M |
Lot | 2.6K | 656.62K |
Turnover | 620.8M | 9.71B |
Average Price | 2,386.79 | 147.94 |
Value | 620.8M | 9.71B |
Indicative Equilibrium Price | 2,390 | 150 |
Indicative Equilibrium Volume | 25 | 8.52K |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Widyahusada Tbk (the Company) was established based on the Deed of Notary Sri Rahayu, SH, No. 14 dated February 8, 1988. Clinical Laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few idealists pharmaceutical educational background.
Read more on PRDA →PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Read more on UVCR →